Article info

Download PDFPDF
Feasibility of Trials in Ovarian Cancer by Line of Therapy and Platinum Sensitivity

Authors

  • Roekshana Shaboodien Ovarian Cancer Action Research Centre, Division of Oncology, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom. PubMed articlesGoogle scholar articles
  • Nikolaos Diamantis Ovarian Cancer Action Research Centre, Division of Oncology, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom. PubMed articlesGoogle scholar articles
  • Sarah Blagden Ovarian Cancer Action Research Centre, Division of Oncology, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom. PubMed articlesGoogle scholar articles
  • Hani Gabra Ovarian Cancer Action Research Centre, Division of Oncology, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom. PubMed articlesGoogle scholar articles
  • Roshan Agarwal Ovarian Cancer Action Research Centre, Division of Oncology, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Roshan Agarwal, PhD, MBChB, FRCP, Division of Oncology, Hammersmith Hospital Campus, Imperial College London, Du Cane Rd, London, W12 0NN, United Kingdom. E-mail: roshan.agarwal{at}imperial.ac.uk.

Citation

Shaboodien R, Diamantis N, Blagden S, et al
Feasibility of Trials in Ovarian Cancer by Line of Therapy and Platinum Sensitivity

Publication history

  • Received October 23, 2012
  • Accepted December 30, 2012
  • First published March 1, 2013.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.